Goodwin has added its sixth litigation partner in two years. The growth has centered on the convergence of technology in multiple industries. A lot of emerging companies are treading new ground and building a whole new, disrupting industry. Read the Daily Journal Article here.
Related Content
- InsightMarch 25, 2024
Antitrust & Competition Technology 2023 Year in Review
- AlertMarch 15, 2024
In Continuing Efforts to Incentivize Self-Disclosures and Cooperation, DOJ Announces Pilot Program to Pay Criminal Whistleblowers
- InsightMarch 11, 2024
Antitrust & Competition Healthcare Year in Review 2023
- InsightMarch 6, 2024
Employment Status — A View From Both Sides of the Pond
- AlertFebruary 26, 2024
DOJ Renews Focus on Private Equity Amid Record False Claims Act Enforcement
- InsightFebruary 22, 2024
Antitrust & Competition Life Sciences Year in Review 2023
- AlertFebruary 2, 2024
Foreign Extortion Prevention Act (FEPA) Expands US Authority to Reach Foreign Bribery
- AlertNovember 21, 2023
SEC Announces an Increase in Total Enforcement Actions in FY 2023, with Close to $5 Billion in Financial Penalties, the Second Highest Amount in SEC History
- Speaking EngagementsMay 9, 2024
ACI's 19th FCPA & Anti-Corruption for the Life Sciences Industry
- EventsMay 5, 2024
2024 MBA Legal Issues and Regulatory Compliance Conference
- WebinarApril 3, 2024
2023-2024 Key Trends and Updates: Securities Litigation Against Life Sciences Companies
- Awards and RankingsMarch 28, 2024
Sabrina Rose-Smith and William Jay Named to Forbes’ List of America’s Top 200 Lawyers
- WebinarMarch 27, 2024
Abortion at the Supreme Court (Again)
- Awards and RankingsMarch 20, 2024
The American Lawyer Names Rachael Bushey and Jennifer Porter 2024 Dealmakers of the Year
- In the PressFebruary 28, 2024
Preparing for Lawsuits Challenging a Company’s Sale of Securities (Daily Journal)
- In the PressFebruary 26, 2024
Hemp-Derived Delta-9 THC: What’s Next? (Cannabis Business Times)